Atom Investors’s LeonaBio Inc LONA Stock Holding History

Atom Investors’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,202	Closed	-$37K	–	287
2022 Q2	$37K	Buy	+1,202	New	+$110K	0.02%	236

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atom Investors's LONA Position: Q3 2022 in Review

Atom Investors sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 1,202 shares — an estimated $37K sold.

Atom Investors first reported a position in LONA in Q2 2022 and held it in 1 quarter. The position peaked at $37K in Q2 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

Atom Investors reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
Atom Investors sold 1,202 LeonaBio Inc shares in Q3 2022, an estimated $37K.
Atom Investors first reported a position in LeonaBio Inc in Q2 2022 and held it in 1 quarter.
Atom Investors's LeonaBio Inc position peaked at $37K in Q2 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on Atom Investors's 13F filing for Q3 2022, filed 8 Nov 2022.